Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 2

Natalizumab: A new treatment for relapsing remitting multiple sclerosis

       
Total article views   HTML views PDF downloads Totals
6,733 Dovepress* 6,733+ 2,307 9,040
Totals 6,733 2,307 9,040
*Since 15 May 2007
+Since July 2016

View citations on Google Scholar